نتایج جستجو برای: induction chemotherapy

تعداد نتایج: 306098  

Journal: :The Gulf journal of oncology 2007
W Hamouda Y Dorgham A Yosry M Abdel Wahab

OBJECTIVE The objective of this study was to evaluate the role of neoadjuvant chemotherapy in the treatment of locally advanced non small cell lung cancer (NSCLC) followed by radiotherapy versus radiotherapy alone. MATERIAL AND METHODS Sixty nine patients were randomized to chemotherapy (group A) or radiotherapy alone (group B). The induction chemotherapy consists of cisplatin (80 mg/m2) day ...

2016
Chen-Hua Yan Yu Wang Jing-Zhi Wang Yu-Hong Chen Yao Chen Feng-rong Wang Yu-Qian Sun Xiao-Dong Mo Wei Han Huan Chen Xiao-hui Zhang Lan-Ping Xu Kai-Yan Liu Xiao-Jun Huang

BACKGROUND Persons with acute leukemia relapsing after allotransplant and who respond to anti-leukemia interventions are at high risk of a second relapse. We studied the impact of minimal residual disease (MRD)- and graft-vs.-host disease (GvHD)-guided multiple consolidation chemotherapy and donor lymphocyte infusions (DLIs) to prevent second relapse in patients with acute leukemia relapsing po...

Journal: :Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2017
Ramaswamy Govindan Aleksandra Szczesna Myung-Ju Ahn Claus-Peter Schneider Pablo Fernando Gonzalez Mella Fabrice Barlesi Baohui Han Doina Elena Ganea Joachim Von Pawel Vladimir Vladimirov Natalia Fadeeva Ki Hyeong Lee Takayasu Kurata Li Zhang Tomohide Tamura Pieter E Postmus Jacek Jassem Kenneth O'Byrne Justin Kopit Mingshun Li Marina Tschaika Martin Reck

Purpose Patients with squamous non-small-cell lung cancer (NSCLC) have poor prognosis and limited treatment options. This randomized, double-blind, phase III study investigated the efficacy and safety of first-line ipilimumab or placebo plus paclitaxel and carboplatin in advanced squamous NSCLC. Patients and Methods Patients with stage IV or recurrent chemotherapy-naïve squamous NSCLC were rand...

Journal: :Annals of oncology : official journal of the European Society for Medical Oncology 2004
L Licitra J B Vermorken

After approximately 20 years of conflicting results from chemotherapy in randomized trials in advanced head and neck cancer, three meta-analyses reviewed its use. All three concluded that chemotherapy was associated with a statistically significant advantage in survival, but that this was low (4% absolute benefit at 2 and 5 years). The improvement in survival was mainly based on the more robust...

Journal: :Acta medica Okayama 1979
I Kimura T Ohnoshi Y Nakata K Takasugi M Fujii K Hayashi M Kataoka M Sato R Nishihara

Clinical trials of immuno-chemotherapy were conducted on malignant lymphoma patients. Patients during the period from 1972 through 1977 were allocated to two groups retrospectively according to the mode of treatment, i.e., chemotherapy alone (historical control group, 35 patients) and chemotherapy with OK-432 (treated group, 15 patients). Comparisons were made of the two groups, which were homo...

Journal: :The New England journal of medicine 2007
Marshall R Posner Diane M Hershock Cesar R Blajman Elizabeth Mickiewicz Eric Winquist Vera Gorbounova Sergei Tjulandin Dong M Shin Kevin Cullen Thomas J Ervin Barbara A Murphy Luis E Raez Roger B Cohen Monica Spaulding Roy B Tishler Berta Roth Rosana del Carmen Viroglio Varagur Venkatesan Ilya Romanov Sanjiv Agarwala K William Harter Matthew Dugan Anthony Cmelak Arnold M Markoe Paul W Read Lynn Steinbrenner A Dimitrios Colevas Charles M Norris Robert I Haddad

BACKGROUND A randomized phase 3 trial of the treatment of squamous-cell carcinoma of the head and neck compared induction chemotherapy with docetaxel plus cisplatin and fluorouracil (TPF) with cisplatin and fluorouracil (PF), followed by chemoradiotherapy. METHODS We randomly assigned 501 patients (all of whom had stage III or IV disease with no distant metastases and tumors considered to be ...

Journal: :European journal of haematology 2008
Michele Malagola Annalisa Peli Daniela Damiani Anna Candoni Mario Tiribelli Giovanni Martinelli Pier Paolo Piccaluga Stefania Paolini Francesco De Rosa Francesco Lauria Monica Bocchia Marco Gobbi Ivana Pierri Alfonso Zaccaria Eliana Zuffa Patrizio Mazza Giancarla Priccolo Luigi Gugliotta Alessandro Bonini Giuseppe Visani Cristina Skert Cesare Bergonzi Aldo Maria Roccaro Carla Filì Renato Fanin Michele Baccarani Domenico Russo

OBJECTIVES Infections are the major cause of morbidity and mortality in patients with acute myeloid leukaemia (AML). They primarily occur during the first course of induction chemotherapy and may increase the risk of leukaemia relapse, due to a significant delay in consolidation therapy. The intensification of induction chemotherapy and the use of non-conventional drugs such as fludarabine are ...

2017
Karen K. Fu

Chemotherapy has often been combined with radiotherapy and/or surgery in the treatment of patients with advanced head and neck cancer in an attempt to improve locoregional control, decrease distant metastasis, and increase survival. Recently, induction chemotherapy has been used in the selection of patients with advanced resectable carcinoma of the larynx and hypopharynx for organ preservation....

Journal: :Lung cancer 2007
Federico Rea Giuseppe Marulli Luigi Bortolotti Cristiano Breda Adolfo Gino Favaretto Lucio Loreggian Francesco Sartori

BACKGROUND Trimodality therapy seems to be the best treatment for malignant pleural mesothelioma (MPM). A large experience served to evaluate the efficacy of surgery followed by adjuvant chemo-radiotherapy. Trimodality therapy results have led us to test induction chemotherapy followed by EPP and adjuvant radiotherapy in stages I-III of MPM. The aim of our study was to evaluate the feasibility ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید